INFLA HARMONY™: Turmeric, Boswellia, Quercetin, Ginger, Alpha-Lipoic Acid

No. France’s food safety agency, ANSES, states this as a definition, not a note of caution: “A food supplement is not a medicine, and can therefore not, by definition, claim any therapeutic effect.”

Assurance Maladie, France’s national health insurance body, explicitly places these products in the category of self-medication: “Spontaneous consumption of food supplements, or their use as an alternative therapeutic approach, can amount to self-medication. Indeed, these products are generally sold with claims that often point towards improved health and well-being. Yet they can interact with one or more medicines.”

It also describes, regarding self-medication continued beyond the recommended duration, the exact mechanism we refuse to encourage: “this behaviour can lead to delaying a consultation during which the doctor could detect a more serious problem.”

Pain that persists should be assessed and treated through a consultation. A food supplement replaces neither a diagnosis, nor a treatment, nor the advice of a doctor, pharmacist or physiotherapist. If this is your situation, start by making an appointment.

Sources (French agencies, quotes translated from French): ANSES, “Food supplements: the need for informed consumption,” published 21 March 2025, anses.fr/fr/content/les-complements-alimentaires-necessite-dune-consommation-eclairee; Assurance Maladie, “Self-treating with self-medication,” 11 September 2025, ameli.fr/assure/sante/medicaments/utiliser-recycler-medicaments/automedication. Accessed 22 August 2026.

It is a flavonoid, a family of plant compounds widespread in everyday food. It is found in particular in onions, capers, apples and certain berries. It belongs to the same broad group of molecules as those studied for their antioxidant activity.

One point deserves to be stated clearly: to date, EFSA has not authorised any health claim relating to quercetin. You will therefore find no promise about it on this page, and a page that makes one steps outside the regulatory framework.

What this formula can tell you, verifiably: it provides 300 mg per daily dose, as an extract standardised to 85%.

Source: EFSA, “Health claims” topic page, efsa.europa.eu. Accessed 28 August 2026.

Boswellia serrata is a tree from which gum resin is harvested. This resin contains boswellic acids, the molecules on which extract standardisation is based. This is why a serious extract states a boswellic acid content rather than a simple plant quantity.

Boswellia is among the plants whose joint-health statements remain usable under the transitional regime provided for in Article 28 of the European regulation on claims. On this basis, and this basis only, this page states that boswellia contributes to the health of joints and bones.

In this formula: 307 mg per daily dose, standardised to 65%, providing 200 mg of boswellic acids.

Source: Regulation (EC) No 1924/2006, Article 28; EFSA, “Health claims” topic page. Accessed 28 August 2026.

Like any concentrated plant, it calls for precautions, and ANSES, France’s food safety agency, notes that responsibility for the information lies with the manufacturer, since “the marketing of food supplements does not require market authorisation.”

The people for whom this complete formula is not recommended are listed in the Precautions for Use tab on this page, and we display them before purchase rather than on the back of the bottle. These include, in particular, situations linked to biliary function, pregnancy and breastfeeding, as well as certain ongoing treatments.

The right approach in every case: ANSES puts the advice of a health professional at the top of its recommendations, and asks people to “report their consumption of food supplements to their doctor or pharmacist.”

Source (French agency, quotes translated from French): ANSES, “Food supplements: the need for informed consumption,” 21 March 2025. Accessed 28 August 2026.

Both approaches respond to the same observation: curcumin, taken as it is, passes very poorly into the bloodstream. They go about it differently.

Piperine, extracted from black pepper, acts on the metabolism of curcumin and slows its elimination. It is the most widespread solution, and the least costly to formulate. There is a consequence worth knowing: piperine also affects the way the body metabolises other substances, which makes a pharmacist’s advice useful if you are on ongoing treatment.

The second approach encapsulates curcumin in a solid lipid particle. This is the route chosen here, with Longvida®, and this formula therefore contains no piperine. 400 mg per daily dose, including 92 mg of curcuminoids.

Neither approach is superior in absolute terms. They are two methods, and you have the right to know which one you are buying.

For a reason of measurement. Turmeric powder is dosed by the spoonful, with a curcuminoid content that varies from one rhizome to another and from one harvest to another. A capsule of standardised extract provides the same amount of active molecule at every dose, and that amount is measured and then published.

This is also what makes comparison between two products possible. Two powders cannot be compared, two standardisations can.

Here: 120 capsules per bottle, four a day, thirty days. The full daily dose corresponds to the five lines published on this page.

No, and the reason lies in the form of the actives. Longvida® curcumin is a formulated ingredient, obtained through a patented encapsulation process, which does not fall under organic certification. The choice was therefore made on extraction form rather than on the label.

This is a deliberate trade-off, and it compares honestly: a standardised organic turmeric would give you a certified plant; this formula gives you five standardised extracts whose amounts and standardisation are published. These are two different criteria, and the right one depends on what you are looking for.

Manufacturing is French, as with our entire range of supplements.

No, and this is what ANSES, France’s food safety agency, states in an opinion devoted to food supplements containing anti-inflammatory plants: “Inflammation is a natural defence process and does not need to be fought when it is not excessive.”

The same opinion sets out a limit that we repeat as it stands: “Given the available data, it cannot be excluded that consuming plants with anti-inflammatory or immunomodulatory properties may hinder the body’s natural defences.” The Agency recommends that consumers “refer to their doctor if plants covered by this opinion are identified in the composition of a supplement they take, particularly if they are being treated for a chronic inflammatory condition.”

Turmeric and boswellia are among the plants covered by this opinion. Two of the five actives in this formula are therefore directly concerned. We would rather write this for you than let you discover it.

Source (French agency, quotes translated from French): ANSES, opinion on referral No. 2020-SA-0045, 10 April 2020, anses.fr/system/files/NUT2020SA0045.pdf. Accessed 22 August 2026.

Four capsules, and five actives:

• Longvida® Curcumin: 400 mg, including 92 mg of curcuminoids, patented solid lipid particle process.
• Boswellia serrata: 307 mg, extract standardised to 65%, providing 200 mg of boswellic acids.
• Quercetin: 300 mg, extract standardised to 85%.
• Ginger extract: 300 mg, standardised for gingerols, providing 15 mg of gingerols.
• Alpha-lipoic acid: 300 mg, obtained by controlled synthesis, purified to 100%.

The full table is available in the Ingredients tab, at the top of this page. Turmeric and boswellia contribute to joint health.

Four questions are enough, and they work for any product on the shelf.

Does the stated figure apply to one capsule or to the full dose? A product showing 500 mg per capsule taken once a day does not provide the same thing as a product showing 500 mg across four capsules.

How many active molecules, not just how much extract? 400 mg of an extract standardised to 20% provides 80 mg of active. Without a stated standardisation, the calculation is impossible.

In what form was the active extracted? Plain powder, concentrated extract and encapsulated form are three different things, and the raw milligram figure does not make them comparable.

Who is the product not recommended for? An honest label says so before purchase.

Because that is its nature. ANSES, France’s food safety agency, describes it as follows, through the voice of the coordinator of its expert assessment: “Curcumin has very low bioavailability, meaning it passes into the bloodstream with difficulty and is eliminated very quickly by the body. Manufacturers have developed various formulations to improve this bioavailability and so increase the effects of curcumin.”

The Agency classifies these formulations into two families. The classic forms: “turmeric rhizome powder,” “turmeric extracts, whether or not enriched in curcumin.” The new forms that increase bioavailability: “combinations of curcumin with piperine or turmeric essential oil,” then “more elaborate forms: phytosomal complex, micelle, colloidal nanoparticles, cyclodextrin encapsulation…”

The curcumin used here, Longvida®, is encapsulated in a complex of phospholipids and fatty acids. It therefore belongs to the second family. This has practical consequences, detailed in the next question.

Source (French agency, quotes translated from French): ANSES, “Adverse effects linked to the consumption of food supplements containing turmeric,” 27 June 2022, anses.fr/fr/content/des-effets-indesirables-lies-la-consommation-de-complements-alimentaires-contenant-du. Accessed 22 August 2026.

This is the question we wish we had seen asked elsewhere. ANSES notes that “EFSA has set the acceptable daily intake (ADI) at 180 mg of curcumin per day for a 60 kg adult” and that it has itself “determined that the amount provided by food supplements should remain below 153 mg per day for a 60 kg adult.”

Then comes the caveat: “the Agency stresses that this figure is valid only for food supplement formulations containing curcumin in classic form.” And the warning: “Even where they do not appear to exceed the ADI, these new formulations may carry a risk of adverse health effects by increasing the bioavailability of curcumin in the body. To date, the food supplement label rarely states whether the formulation is classic or new.”

Our label states it, and so does this page: the formula provides 92 mg of curcuminoids per daily dose of four capsules, in encapsulated form. The 153 mg benchmark therefore does not apply to it as it stands. Do not exceed the stated dose, and seek medical advice if you are on ongoing treatment.

Source (French agency, quotes translated from French, figures originally set by EFSA): ANSES, “Adverse effects linked to the consumption of food supplements containing turmeric,” 27 June 2022. Accessed 22 August 2026.

This question is not settled on a product page. It is settled with your doctor or pharmacist, with the composition in front of them.

What we can do is give you the elements. ANSES, France’s food safety agency, “advises against the consumption of turmeric-based food supplements by people suffering from disorders of the biliary tract.” It adds: “there is a risk linked to interactions between curcumin and certain medicines such as anticoagulants, anticancer medicines and immunosuppressants. Their efficacy or safety could be affected. The Agency therefore advises against the consumption of food supplements containing turmeric by people treated with these medicines without medical advice.”

In its 2020 opinion, the Agency also recommends “avoiding multiple sources of exposure to these plants, owing to the risk of cumulative intake and additive effects that could lead to adverse effects.”

The full composition, active by active, with amounts and standardisation, is set out in the Ingredients tab on this page. Show it to them.

Sources (French agency, quotes translated from French): ANSES, article of 27 June 2022; ANSES, opinion on referral No. 2020-SA-0045, 10 April 2020. Accessed 22 August 2026.

Yes, and it would be dishonest not to state this on the page of a product that contains it. ANSES, France’s food safety agency, reports that “Italy has recorded around twenty cases of hepatitis involving food supplements containing turmeric” and that “in France, ANSES’s nutrivigilance scheme has recorded more than 100 reports of adverse effects potentially linked to the consumption of food supplements containing turmeric or curcumin, including 15 cases of hepatitis.”

This nutrivigilance scheme has existed since 2009 and works in both directions: it “makes it possible to collect and identify adverse effects reported by health professionals, in particular doctors and pharmacists, manufacturers or distributors, as well as any member of the public.” If you notice an adverse effect, report it.

Sources (French agency, quotes translated from French): ANSES, article of 27 June 2022; ANSES, “Food supplements: the need for informed consumption,” 21 March 2025. Accessed 22 August 2026.

ANSES, France’s food safety agency, publishes five pieces of advice, which we reproduce without editing: “Seek advice from a health professional,” “Avoid prolonged, repeated or multiple use,” “Follow the conditions of use,” “Be wary of products presented as miracle cures,” “Favour products sold through the best-controlled channels.”

It also recommends starting with a question: “Before consuming a food supplement, the first question to ask is: do I really need it?”

On the label itself, three figures are worth looking for on each plant: the amount of extract per daily dose, the standardisation of that extract, and the nature of the extraction process. All three appear on this page. Their absence elsewhere is information in itself.

Source (French agency, quote translated from French): ANSES, “Food supplements: the need for informed consumption,” published 21 March 2025. Accessed 22 August 2026.

Because European law strictly governs what a food is entitled to claim. EFSA states the objective of Regulation 1924/2006: “One of the key objectives of this Regulation is to ensure that any claim made on a food label in the EU is clear and substantiated by scientific evidence.” And it is the Authority that carries out this verification: “EFSA is responsible for verifying the scientific substantiation of the submitted claims.”

On the French side, ANSES, France’s food safety agency, summarises the situation: claims “are strictly governed by European regulation,” and “to date, a limited number of health claims are authorised.” None of them covers the plants in this formula.

When a page nonetheless promises you a result, it does not have access to some science that others lack. It has simply chosen not to stay within the framework.

Sources: EFSA, “Health claims” topic page, efsa.europa.eu/en/topics/topic/health-claims; ANSES (French agency, quote translated from French), “Food supplements: the need for informed consumption,” 21 March 2025. Accessed 22 August 2026.

One nuance exists, however, and we apply it. Among the claims still pending are statements relating to joint health, usable under the transitional regime provided for in Article 28 of the Regulation. On this basis, and this basis only, this page states that turmeric and boswellia contribute to joint health. No statement referring to a disease is possible, and you will find none here.

It is not recommended in cases of biliary obstruction or biliary function disorders, for pregnant or breastfeeding women, for people with diabetes, or when taking anticoagulants, anticancer medicines or immunosuppressants.

Do not exceed the recommended daily dose. This product is not a substitute for a varied, balanced diet or a healthy lifestyle. Keep out of reach of young children.

If you are on any ongoing treatment, seek the advice of a doctor or pharmacist before the first dose.

Every page in this range describes one and the same product: the same actives, the same amounts, the same 120-capsule bottle, the same dose of four capsules a day. Nothing changes in the jar. What changes is the angle from which we explain the composition, and the path by which you arrived here.

This page is written for readers who want to understand a formula before choosing one: extraction forms, standardisation, regulatory limits, precautions. Other pages cover the same composition from a different angle, drawing on the same public sources: the page written for readers over 50, the tendinitis supplement page, the page that details the comparison criteria, the page devoted to days spent sitting, the page focused on the lower back.

Whichever you choose, the full composition appears in the Ingredients tab on this page. Four options: single purchase, a pack of 2, a pack of 3, or a monthly subscription at €29.90 instead of €39.90, cancellable at any time.

On the topic of joints, European regulation authorises one statement under the pending claims: boswellia contributes to the health of joints and bones. This formula provides 307 mg per daily dose, as a concentrated extract standardised to 65% boswellic acids, providing 200 mg of boswellic acids.

Beyond this sentence, nothing more can be stated, by us or by anyone else.

The same framework applies: turmeric contributes to joint health. This formula provides 400 mg of Longvida® curcumin, including 92 mg of curcuminoids, extracted using the patented “Solid Lipid Curcumin Particle” technology.

As ordinary curcumin is very poorly absorbed, it was the form that guided this choice, not the raw quantity. Here again, nothing else can be stated.